IDEX Corporation provided earnings guidance for the year 2022. For the period, the company's organic sales growth is projected to be approximately 12% over the prior year period, with a 9 % organic sales increase in the fourth quarter of 2022 versus the prior year period. The Company expects full year 2022 reported EPS attributable to IDEX of $7.75 to $7.80 (adjusted EPS attributable to IDEX of $8.04 to $8.09).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
218 USD | +0.40% | -2.77% | +0.41% |
05-16 | IDEX Biometrics Completes Upsized NOK55 Million Share Placement | MT |
05-08 | Declaration of Voting Results by IDEX Corporation | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.41% | 16.43B | |
-4.33% | 14.06B | |
-5.61% | 5.12B | |
+2.47% | 4.58B | |
+7.43% | 3.18B | |
+34.15% | 1.95B | |
+88.45% | 1.69B | |
+1.50% | 1.24B | |
+18.66% | 1.06B | |
-6.56% | 867M |
- Stock Market
- Equities
- IEX Stock
- News IDEX Corporation
- Idex Corporation Provides Earnings Guidance for the Year 2022